15919CRETO-EAP-NCT06443944OpenAn Expanded Access Program of Cretostimogene Grenadenorepvec in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)CRETO-EAPNCT06443944IndustrialAdultTreatmentIVGlobalOtherStamatakis, LambrosMedStar Health and GUMC; Medstar Washington Hospital CenterGenito-urinaryOncology GroupMHRI Washington Cancer Institute2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>